{
  "id": "killip_classification",
  "title": "Killip Classification for Heart Failure",
  "description": "Quantifies heart failure severity in acute coronary syndrome (STEMI or NSTEMI) and predicts 30-day mortality. Based on physical examination findings to stratify risk in myocardial infarction patients.",
  "category": "cardiology",
  "version": "1967_killip",
  "parameters": [
    {
      "name": "killip_class",
      "type": "string",
      "required": true,
      "description": "Killip class based on clinical presentation",
      "options": [
        {
          "value": "class_i",
          "label": "Class I - No signs of congestion",
          "description": "No clinical signs of heart failure"
        },
        {
          "value": "class_ii",
          "label": "Class II - S3 and basal rales on auscultation",
          "description": "Rales in the lungs, third heart sound (S3), and/or elevated jugular venous pressure"
        },
        {
          "value": "class_iii",
          "label": "Class III - Acute pulmonary edema",
          "description": "Overt pulmonary edema with rales throughout lung fields"
        },
        {
          "value": "class_iv",
          "label": "Class IV - Cardiogenic shock",
          "description": "Cardiogenic shock with hypotension (SBP <90 mmHg) and evidence of peripheral vasoconstriction"
        }
      ],
      "validation": {
        "enum": ["class_i", "class_ii", "class_iii", "class_iv"]
      }
    }
  ],
  "result": {
    "name": "killip_result",
    "type": "object",
    "unit": "classification",
    "description": "Killip classification with mortality risk estimates"
  },
  "interpretation": {
    "ranges": [
      {
        "class": "I",
        "description": "No signs of congestion",
        "mortality_30_day": "2-3%",
        "in_hospital_mortality": "<6%",
        "interpretation": "Low risk. No clinical signs of heart failure. Standard ACS management appropriate."
      },
      {
        "class": "II",
        "description": "S3 and basal rales",
        "mortality_30_day": "5-12%",
        "in_hospital_mortality": "<17%",
        "interpretation": "Moderate risk. Mild-moderate heart failure. Consider diuretics and close monitoring."
      },
      {
        "class": "III",
        "description": "Acute pulmonary edema",
        "mortality_30_day": "10-20%",
        "in_hospital_mortality": "38%",
        "interpretation": "High risk. Severe heart failure with pulmonary edema. Aggressive treatment including diuretics, vasodilators, and consider mechanical support."
      },
      {
        "class": "IV",
        "description": "Cardiogenic shock",
        "mortality_30_day": "10-20%",
        "in_hospital_mortality": "81%",
        "interpretation": "Very high risk. Cardiogenic shock requires immediate intervention including inotropes, mechanical circulatory support, and urgent revascularization."
      }
    ]
  },
  "references": [
    "Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967 Oct;20(4):457-64.",
    "Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, Topol EJ. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003 Oct 22;290(16):2174-81.",
    "Mello BH, Oliveira GB, Ramos RF, Lopes BB, Barros CB, Carvalho Ede O, et al. Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction. Arq Bras Cardiol. 2014 Aug;103(2):107-17.",
    "DeGeare VS, Boura JA, Grines LL, O'Neill WW, Grines CL. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2001 May 1;87(9):1035-8."
  ],
  "formula": "Clinical classification based on physical examination findings: Class I (no heart failure) â†’ Class IV (cardiogenic shock)",
  "notes": [
    "Originally developed in 1967 before reperfusion therapy era",
    "Still validated and predictive in modern era with PCI and thrombolytics",
    "Simple bedside assessment requiring only physical examination",
    "Useful for rapid risk stratification in emergency settings",
    "Can guide treatment decisions including reperfusion therapy and mechanical support",
    "Mortality rates have decreased since original study due to modern therapies",
    "Should be used as part of full clinical assessment, not in isolation",
    "Applies to both STEMI and NSTEMI patients"
  ]
}